US Patent Issued to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) on Nov. 3 for "Stabilized Ace2 variant, Ace2-fc fusion protein using same, and method for preventing or treating COVID-19" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,020, issued on Nov. 3, was assigned to IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (Seoul, South Korea).

"Stabilized Ace2 variant, Ace2-fc fusion protein using same, and method for preventing or treating COVID-19" was invented by Seong Eon Ryu (Seoul, South Korea) and Myeong Bin Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A stabilized Ace2 variant has a disulfide bond introduced by substituting cysteine for amino acid residue pairs at specific positions of the Ace2 protein, thereby having excellent stability. The stabilized Ace2 variant exhibits high binding affinity for SARS-CoV-2 virus and exc...